" Let Genesis be the first stop in your search for a good fertility centre in seeking joyful parenthood."

Dr. Tazeem Shaik

MD, DNB, MS (USA)
Consultant Gynaecologist

Dr. Tazeem Shaik is a Consultant Gynecologist at Genesis Fertility and Laparoscopy Centre since Jan 2018. She received her medical degree from Kurnool Medical College and completed her three-year residency in Obstetrics and Gynecology. Dr. Tazeem has come to us with a very strong education and background, having graduated from medical school with honors; and several awards and gold medal for her academic excellence.

Dr. Tazeem Shaik is a Gynecologist and medical scientist with an interest in Reproductive Medicine and Gynaecological Oncology. As a physician, she aimed to improve outcomes for patients through clinical care as well as research. She strongly believes that research is the key to developing better treatments. To this effect, she began this pursuit by joining Medical Scientist Postdoctoral Graduate Program in the United States at the Rutgers University – Robert Wood Johnson Medical School, a world-renowned institution. Here, Dr. Tazeem Shaik has worked as a clinical investigator on the development of superior and novel targeted molecular anticancer drugs against the most common cancers in the United States and worldwide. In 2014 while working in Rutgers Robert Wood University Hospital, United States, she received the “Gold Doc”  Certificate and lapel pin from The Arnold P. Gold Foundation, USA. The ‘Gold Doc’ is recognition for humanism in medicine. It is a very distinctive honor to be one among about a hundred physicians recognized nationally by the Foundation, since this award is both a proof and a constant reminder that her skills, experience, and compassion make a remarkable difference in the lives of patients.

She has presented her original research work at several international and national annual scientific meetings. Most of her cancer research findings have been published as priority research papers in Oncotarget, Molecular Biology of the Cell, and Cancer Research which are all leading international medical journals.

She has been invited to judge original research submitted to major international journals in Obstetrics and Gynecology including the American Journal of Obstetrics & Gynecology (AJOG), Obstetrics & Gynecology (The Green Journal), and the BJOG: An International Journal ofb Obstetrics and Gynecology (BJOG). She is also an editor for the gynecology section of aninternational Clinical Journal.

Through these activities Dr. Tazeem stays abreast of the most recent and cutting-edge fertility treatments and strives to provide evidence-based medicine to all patients; but at the same time also recognizes the importance of personalized approach to tailor the treatment options for achieving success in fertility and pregnancy.

Dr. Tazeem Shaik is compassionate and methodical. She believes patients deserve an honest and thorough explanation before embarking on fertility journey together.

Scientific Publications

Tazeem Shaik, Gulam M. Rather, Nitu Bansal, Tamara Minko, Olga Garbuzenko, Zoltan Szekely, Emine E. Abali, Debabrata Banerjee, John E. Kerrigan, Kathleen W. Scotto, Joseph R. Bertino. (2018). Modeling and antitumor studies of a modified L-penetratin peptide targeting E2F in lung cancer and prostate cancer. Oncotarget, 9(70), 33249–33257. doi:10.18632/oncotarget.26064

Tazeem Shaik, Nitu Bansal, Nadine Johnson Farley, John Kerrigan, Olga Garbuzenko, Tamara Minko, Emine Abali, Zoltan Szekely, Kathleen Scotto, Debabrata Banerjee, Joseph Bertino. Antitumor studies of an E2f1 promoter sequence binding peptide – penetratin conjugate as a molecule targeting E2f in prostate cancer. In: Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18-22; Philadelphia, PA. Philadelphia (PA):AACR; Cancer Res 2015;75(15 Suppl):Abstract nr 1237. doi:10.1158/1538-7445.AM2015-1237

T. Shaik, N. Bansal, N.J. Farley, J. Kerrigan, E.E. Abali, D. Banerjee, J.R. Bertino (2014) Antitumor studies of Modified L– Penetratin Peptide as a molecule targeting E2F in Prostate Cancer. Mol. Biol. Cell 25, page 222-223. doi:10.1091/mbc.E14-10-1437.

Surasak Puvabanditsin, Melissa February, Tazeem Shaik, Arun Kashyap, Chantal Bruno & Rajeev Mehta. 2q31.1 microdeletion syndrome: case report and literature review. Clinical Case Reports 2015; 3(6): 357–360. doi: 10.1002/ccr3.260

Xie X, Bansal N, Shaik T, Kerrigan JE, Minko T, Garbuzenko O, Abali EE, Johnson-Farley N, Banerjee D, Scotto KW, Bertino JR. A novel peptide that inhibits E2F transcription and regresses prostate tumor xenografts. Oncotarget. 2014 Feb 28;5(4):901-907.

If you are struggling to have a baby, get in touch with the fertility experts at Genesis Fertility and Laparoscopy Centre. They will help you with your medical check-up, diagnose the underlying fertility disorders, and address your concerns before suggesting a genuine treatment to help you conceive and deliver a healthy baby.

Genesis Fertility and Laparoscopy Centre has state-of-the-art infrastructure, the latest medical equipment, and experienced fertility experts. There is a huge array of satisfied patients who have been able to witness parenthood care at Genesis Fertility and Laparoscopy Centre.

To Experience the joy of holding your little one in your arms, schedule an appointment at Genesis Fertility and Laparoscopy Centre today!

For More Information or

To Get Started on Your Journey Today !

× Whatsapp us